Seeking Alpha

Perrigo (PRGO) says its received final FDA approval for its clobetasol propionate shampoo, the...

Perrigo (PRGO) says its received final FDA approval for its clobetasol propionate shampoo, the generic equivalent of Clobex Shampoo for the treatment of moderate to severe scalp psoriasis. The company will begin shipping immediately. Annual sales of both the generic and branded treatment total approximately $57M.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|